Shuangcheng Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHUANGCHENG, and what generic and branded alternatives to SHUANGCHENG drugs are available?
SHUANGCHENG has three approved drugs.
Drugs and US Patents for Shuangcheng
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shuangcheng | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 213081-001 | Sep 7, 2021 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shuangcheng | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 210165-003 | Jan 22, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shuangcheng | PIOGLITAZONE HYDROCHLORIDE | pioglitazone hydrochloride | TABLET;ORAL | 210165-002 | Jan 22, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Shuangcheng | EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 213081-002 | Apr 20, 2022 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.